CellSeed Inc. Logo

CellSeed Inc.

Develops cell sheet products, culture equipment, and offers contract manufacturing services.

7776 | T

Overview

Corporate Details

ISIN(s):
JP3423530009
LEI:
Country:
Japan
Address:
江東区青海2−5−10テレコムセンタービル15F
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CellSeed Inc. is a regenerative medicine company focused on the commercialization of its proprietary 'cell sheet engineering' technology, an innovative therapeutic approach originating in Japan. The company's core business involves the research, development, and manufacturing of cell sheet-based products to treat diseases and disorders. In addition to its therapeutic pipeline, CellSeed develops and sells specialized cell culture equipment and provides contracted development and manufacturing services for cell sheets. The company aims to deliver its novel medical treatments to patients globally, leveraging its expertise in cell culture and production to advance the field of regenerative medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-20 08:01
Registration Form
有価証券届出書(参照方式)
Japanese 154.6 KB
2025-08-14 08:48
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-08-14 08:47
Interim / Quarterly Report
半期報告書-第25期(2025/01/01-2025/12/31)
Japanese 176.2 KB
2025-03-27 06:07
AGM Information
臨時報告書
Japanese 25.6 KB
2025-03-26 08:00
Registration Form
確認書
Japanese 8.1 KB
2025-03-26 08:00
Governance Information
内部統制報告書-第24期(2024/01/01-2024/12/31)
Japanese 21.2 KB
2025-03-26 07:59
Annual Report
有価証券報告書-第24期(2024/01/01-2024/12/31)
Japanese 827.2 KB
2024-08-14 08:15
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-08-14 08:14
Interim / Quarterly Report
半期報告書-第24期(2024/01/01-2024/06/30)
Japanese 181.4 KB
2024-05-15 08:19
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-05-15 08:19
Quarterly Report
四半期報告書-第24期第1四半期(2024/01/01-2024/03/31)
Japanese 145.1 KB
2024-03-28 07:11
AGM Information
臨時報告書
Japanese 22.0 KB
2024-03-28 07:08
Registration Form
確認書
Japanese 8.1 KB
2024-03-28 07:07
Governance Information
内部統制報告書-第23期(2023/01/01-2023/12/31)
Japanese 22.2 KB
2024-03-28 07:04
Annual Report
有価証券報告書-第23期(2023/01/01-2023/12/31)
Japanese 875.2 KB

Automate Your Workflow. Get a real-time feed of all CellSeed Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CellSeed Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CellSeed Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS

Talk to a Data Expert

Have a question? We'll get back to you promptly.